United States· US:63629-9199_4235cd4d-bc60-4a2f-94e5-359fc73d75e5
Cephalexin
A cefalexin product containing cephalexin, registered in United States by Bryant Ranch Prepack. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cefalexin is registered in 14 of 19 countries.
Countries holding a registration under ATC J01DB01 (cefalexin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Cefalexin · ATC J01DB01
14 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefalexin costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $0.72 in United States to $1.28 in Spain — a ×1.8 gap.
- United States: $0.72 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Cefalexin · price per daily dose (2 g)
USD · FX 28 Sept 2026
- ES Spain$1.28
- US United States$0.72 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CEPHALEXIN
- Manufacturer
- Bryant Ranch Prepack
- Country
- United States (US)
- ATC code
- J01DB01
- ATC class
- Cefalexin
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc116362991991500 CAPSULE in 1 BOTTLE (63629-9199-1)
- ndc1163629-9199-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
223 interactions on record for cefalexin.
Graded by severity as the source publishes them — 13 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefalexin · interactions on record
223 records
- 13 moderate
- 210 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- BalsalazideA07EC04moderate
- MetforminA10BA02moderate
- DicoumarolB01AA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefalexin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCefalexin 250mg capsulesMawdsley-Brooks & Company Ltd
- CanadaTEVA-CEPHALEXINTEVA CANADA LIMITED
- IrelandKeflex 250 mg Hard CapsulesFlynn Pharma Limited
- FinlandCefabactin vetLe Vet. Beheer B.V.
- GermanyCefalexin Reiwa HealthcareReiwa Healthcare S.L
- SpainCEFALEXINA NORMON 500 mg CAPSULAS DURASLaboratorios Normon S.A.
- ItalyCEPOREX*8 cpr rivestite 1 gTEOFARMA Srl
- NorwayKeflexOrifarm AS
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Cephalobene, Keflex
- Belgium · Keforal
- Bulgaria · Оспексин
- Cyprus · Felexin, Keflex
- Germany · Cefalexin Reiwa Healthcare, Cephalex-Ct
- Denmark · Keflex
- Spain · Cefalexina Normon, Cefalexina Reiwa Healthcare
- Finland · Kefalex, Kefexin
- France · Keforal, Kéforal
- United Kingdom (Northern Ireland) · Cefalexin, Cefalexin Ascend Laboratories (Uk)
- Croatia · Cefaleksin Belupo, Cefalexin Alkaloid
- Hungary · Cefalexin Reiwa Healthcare, Pyassan 250 Mg Kemény Kapszula
- Ireland · Keflex
- Italy · Ceporex, Keforal
- Luxembourg · Keforal
- Malta · Keflex
- Netherlands · Keforal
- Norway · Keflex
- Poland · Cefaleksyna Tzf
- Romania · Cefalexină Arena, Cefalexina Atb
- Slovakia · Ospexin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f47fdc98-8f93-4264-8c04-c9b704a641dd GET /v1/drugs/f47fdc98-8f93-4264-8c04-c9b704a641dd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "250",
"substance": "CEPHALEXIN",
"productndc": "63629-9199",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA090836",
"marketing_category": "ANDA"
}See everything about cefalexin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.